http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0016092-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
filingDate | 2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce16977e86020434c6159292bd4040ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e85339b230efdebbb9cfe04489bf526 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5166ecc37428f215f05170256cc7f04f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b6cae01493b8bdba56d4f985d64ed4 |
publicationDate | 2002-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-0016092-A |
titleOfInvention | Compound, use of a compound kit for hormonal contraception in a male, and method of treatment |
abstract | "COMPOUND, USE OF A COMPOUND KIT FOR HORMONAL CONTRACEPTION IN A MALE, AND, TREATMENT METHOD". The invention described relates to the unexpected verification of unpublished steroids that are characterized by a 14 <225> -15 <225> -cyclopropane ring and a hydroxymethyl group at 17 <244>. These steroids according to the invention have been found to have an androgenic activity in common. They can be used for the preparation of an agent for male contraception, and also for the preparation of a drug for the treatment of androgen insufficiency. |
priorityDate | 1999-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482 |
Total number of triples: 15.